Thomas Stephen Basil — SEC Form 4 filings
SEC reporting owner CIK 2027962. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-27 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 250,000 shares, $2,246,202 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 100,000 shares @ $13.67 ($1,366,820) in Climb Bio, Inc., filed 2026-09-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Climb Bio, Inc. (CLYM) | Director | 10 | — | 5 legs · 250,000 sh · $2,246,202 | 11 |
Form 4 filings — Thomas Stephen Basil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Climb Bio, Inc. (CLYM) | Sale (S): 100,000 @ $13.67 | EDGAR |
| 2026-06-08 | 4 | Climb Bio, Inc. (CLYM) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Climb Bio, Inc. (CLYM) | Sale (S): 33,687 @ $7.00 · Sale (S): 16,313 @ $7.01 | EDGAR |
| 2026-02-17 | 4 | Climb Bio, Inc. (CLYM) | Sale (S): 90,000 @ $5.23 · Sale (S): 10,000 @ $5.81 | EDGAR |
| 2025-08-11 | 4 | Climb Bio, Inc. (CLYM) | Grant/award (A): 100,375 @ $0 | EDGAR |
| 2025-07-01 | 4 | Climb Bio, Inc. (CLYM) | Option exercise (M): 25,094 · Option exercise (M): 25,094 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Climb Bio, Inc. (CLYM) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | Climb Bio, Inc. (CLYM) | Option exercise (M): 25,093 · Option exercise (M): 25,093 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Climb Bio, Inc. (CLYM) | Option exercise (M): 50,188 · Option exercise (M): 50,188 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | Eliem Therapeutics, Inc. (ELYM) | Grant/award (A): 103,907 · Grant/award (A): 100,375 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2027962 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →